Drugs Made In America Acquisition Corp. DMAA
$10.62
▲ +0.05% 24H
About
Drugs Made In America Acquisition Corp. is a special purpose acquisition company (SPAC) established in 2024 and headquartered in Fort Lauderdale, Florida. The company’s primary purpose is to facilitate a merger, share exchange, asset acquisition, or similar business combination with one or more businesses in the U.S. p…
SectorFinancial Services
ExchangeNASDAQ
IndustryShell Companies
CountryUnited States
Employees0
TickerDMAA
Statistics
Market Cap$358.1M
Revenue (TTM)—
Net Income$5.9M
Net Margin—
EPS—
P/E53.05
P/S—
P/B1.52
EV/EBITDA-126.74
ROE2.6%
Dividend Yield—
Price$10.62
Data: Twelve Data · Revenue = mcap / P/S